Table 2:

Univariate ANOVA of potential clinical predictors of platelet inhibition

DemographicsMean Platelet Inhibition (%)P Value
Age (yr)
    <55 years (n = 22)38.6.752
    >55 years (n = 74)36.7
Sex (No.)
    Women (n = 40)39.1.509
    Men (n = 56)35.7
Medical history
Hypertension (No.)
    No (n = 31)40.4.355
    Yes (n = 65)35.5
Diabetes (No.)
    No (n = 64)40.9.029
    Yes (n = 32)29.4
Hyperlipidemia (No.)
    No (n = 50)33.1.067
    Yes (n = 46)42.2
Coronary artery disease (No.)
    No (n = 75)37.7.652
    Yes (n = 21)35.0
Prior stroke (No.)
    No (n = 68)39.0.254
    Yes (n = 28)32.7
Statin use (n = No.)
    No (n = 38)30.0.012
    Yes (n = 54)42.7
Aspirin use (No.)
    No (n = 19)34.0.491
    Yes (n = 73)38.3